Despite similar kinetics of primary tumor initiation and growth in Vangl2+/+/NDL and Vangl2fl/fl/NDL mice (Additional file 4: Fig. S9a–d), Vangl2-depleted tumors are significantly less metastatic than Vangl2-intact tumors (Fig. 6a–d). The gene discussed is VANGL2; the disease is neoplasm.